Name: MAJI Income Statement - Nextel Medical Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

MAJI - Nextel Medical Corp.

USD | OTC Markets

MAJI Income Statement - Nextel Medical Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q3 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q1 FY 18	Q4 FY 17	Q1 FY 13	Q4 FY 12	Q3 FY 12	Q1 FY 12	Q4 FY 11	Q3 FY 11	Q1 FY 11	Q4 FY 10	Q3 FY 10
Revenues
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	0.0	0.0	0.0	0.0	0.0	0.0
Cost of Revenue	-	-	-	-	-	0.0	-	-	0.0	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	0.0	-	-	0.0	-	-	-	-	-	-	-	-
Operating Expenses
Research & Development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income
Operating Income	(0.1)	(0.2)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.1)	(0.6)	(0.4)	(5.0)	(0.3)
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax & Net
Income Tax Expense	-	0.0	0.0	-	0.0	0.0	-	0.0	0.0	-	-	-	-	-	-
Per Share
EPS Basic	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplementary Data
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2020	FY2019	FY2018	FY2012	FY2011	FY2010
Revenues
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	-
Cost of Revenue	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-
Operating Expenses
Research & Development	-	-	-	-	-	-	-
Selling General & Administrative	-	-	-	-	-	-
Operating Income
Operating Income	(0.4)	(0.5)	(0.1)	(0.0)	(6.0)	(0.1)	-
Non-Operating
Interest Income	-	-	-	-	-	-	-
Interest Expense	-	0.0	0.0	-	0.1	0.0	-
Tax & Net
Income Tax Expense	-	0.0	0.0	0.0	-	-	-
Net Income From Continuing Ops	(0.3)	(0.4)	(0.1)	(0.0)	(6.1)	(0.1)
Per Share
EPS Basic	-	-	-	-	-	-	-
EPS Diluted	-	-	-	-	-	-	-
Supplementary Data
EBITDA	-	-	-	-	-	-	-
EBIT	(0.4)	(0.5)	(0.1)	(0.0)	(6.0)	(0.1)	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)